Evidence map›Paper›PMID 38411057›Full record

ArticleMicrobiology spectrum2024

Yumei Huang, Jiali Cao, Mengpei Zhu, Ziwen Wang, Ze Jin, Zhifan Xiong

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. NontoxigenicMicroorganisms · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Microbiota in cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  13. Food science & nutrition · 2026
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. The influence of endocrine disruptors on the gut microbiota.Turkish journal of medical sciences · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yumei HuangDepartment of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Jiali CaoDepartment of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Mengpei ZhuDepartment of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Ziwen WangDepartment of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Ze JinDepartment of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Zhifan XiongDepartment of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.ORCID 0000-0001-7190-8073
Huazhong University of Science and Technology · CN

Funding

Applied Scientific Research Fund (ASRF) 2023LYYCXTD0002CSU | Fundamental Research Funds for Central Universities of the Central South University (Fundamental Research Funds for the Central Universities of Central South University) YCJJ202201051MOST | National Key Research and Development Program of China (NKPs) 2018YFC2002000
6 · The paper itself

Abstract

Gut microbiota dysbiosis is a prominent determinant that significantly contributes to the disruption of lipid metabolism. Consequently, it is essential to the occurrence and development of non-alcoholic fatty liver disease (NAFLD). Nevertheless, the connection between diet and symbiotic gut microbiota in the progression of NAFLD remains uncertain. The purpose of this study was to explore the role of supplementing commensal

Indexed as

Bacterial InfectionsGastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseAnimalsBacteriaBacteroides fragilisBlood GlucoseDiet, High-FatDysbiosisEndotoxinsLipid MetabolismLiverMiceBlood GlucoseEndotoxinscommensal Bacteroides fragilisgut microbiotahigh-fat dietlipid metabolismnon-alcoholic fatty liver diseaseshort-chain fatty acids

Identifiers

PMID38411057
PMCPMC10986510
OpenAlexW4392191495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.